On October 4 at the National Conference of the Canadian Society of Association Executives (CSAE) in Vancouver, NDMAC was presented with the Associations Make a Better Canada award.
Therapure Biopharma Inc. launched with a pledge to provide Canadian biotech companies specializing in biological protein therapeutics with better access to the global market.
Recent reports of serious illness in infants in East Asia, caused by ingestion of infant formula contaminated by melamine, may be causing public concern.